BeiGene
$205.47
24H
Market Cap
Volume
Supply
Price Chart
About BeiGene - BGNE
BeiGene, Ltd. is a global biotechnology company that focuses on developing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer. The company, which was founded in 2010, operates out of China and has a broad presence across North America, Asia, and Europe.
What are BeiGene's core values and mission statement?
BeiGene, Ltd.'s core values center around being patient-focused, pursuing scientific excellence, and fostering collaboration and innovation in their work. The company's mission statement emphasizes their dedication to discovering, developing, and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer.
Who founded BeiGene and when?
BeiGene, Ltd. was founded by Xiaodong Wang, John V. Oyler, and Wang Yu in 2010.
Who leads BeiGene?
BeiGene, Ltd. is led by its co-founder, chairman, and CEO, John V. Oyler.
Where is BeiGene located, and what is its base country?
BeiGene, Ltd. has its headquarters located in Beijing, China, and the company is based in China.
On which exchanges is BeiGene traded?
BeiGene, Ltd. is traded on the NASDAQ under the ticker symbol BGNE and on the Hong Kong Stock Exchange with the ticker 6160.
Historical data
BeiGene (BGNE) Price Live Data
The live price of BeiGene (BGNE) is $205.47, with a trading volume of 159,581 in the last 24 hours. Wrapstocks updates the BGNE price in real-time. BeiGene is down -0.65% in the last 24 hours. The company has a live market cap of $22,566,563,840.00 and a supply of 109,828,996 BGNE stocks.
BeiGene (BGNE) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 2 hours and 50 minutes.
